About Albila
Albila is a company based in Sisli (Turkey) founded in 2017.. Albila offers products and services including Scorpion Anti-venom. Albila operates in a competitive market with competitors including Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Mithros Bioscience, among others.
- Headquarter Sisli, Turkey
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Albila Serum Biyolojik Ürünler San. Ve Tic. A.Ş.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Albila
Albila offers a comprehensive portfolio of products and services, including Scorpion Anti-venom. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Serum for treating scorpion stings and venom effects
Funding Insights of Albila
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Albila
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Albila
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Albila Comparisons
Competitors of Albila
Albila operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Mithros Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antivenom drugs and pharmaceutical products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Oral therapies for snake bite treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antisera and antitoxins for snake bites and infections are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic kits and therapeutic biologics are manufactured and developed.
|
|
| domain | founded_year | HQ Location |
Develops anti-venom antibodies for medical applications.
|
|
| domain | founded_year | HQ Location |
Develops recombinant humanized antibodies targeted against snake venom.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Albila
When was Albila founded?
Albila was founded in 2017.
Where is Albila located?
Albila is headquartered in Sisli, Turkey. It is registered at Sisli, Istanbul, Turkey.
What does Albila do?
Albila was established in 2017 in Sisli, Turkey, within the biotechnology sector focused on animal health. Antidotes against stings and bites are produced through hyperimmunization of healthy horses. Key products include Scorpion Antiserum, Snake Antiserum, and Rabies Antitoxin, which are formulated to neutralize toxins from scorpions, snakes, and rabies exposure. Operations center on equine-based serum extraction and purification for veterinary and potential human applications.
Who are the top competitors of Albila?
Albila's top competitors include Ophirex, Beijing Kangchen Pharmaceutical and Vins Bio Products.
What products or services does Albila offer?
Albila offers Scorpion Anti-venom.